Titre : Antithrombiniques

Antithrombiniques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Young Adult
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Antithrombiniques : Questions médicales les plus fréquentes", "headline": "Antithrombiniques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Antithrombiniques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-27", "dateModified": "2025-04-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Antithrombiniques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Anticoagulants", "url": "https://questionsmedicales.fr/mesh/D000925", "about": { "@type": "MedicalCondition", "name": "Anticoagulants", "code": { "@type": "MedicalCode", "code": "D000925", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.502.119" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs du facteur Xa", "alternateName": "Factor Xa Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065427", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du facteur Xa", "code": { "@type": "MedicalCode", "code": "D065427", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.502.119.500.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Antithrombiniques", "alternateName": "Antithrombins", "code": { "@type": "MedicalCode", "code": "D000991", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Vicente Vicente", "url": "https://questionsmedicales.fr/author/Vicente%20Vicente", "affiliation": { "@type": "Organization", "name": "Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, U-765, Center for Biomedical Research on Rare Diseases, Murcia, Spain." } }, { "@type": "Person", "name": "Javier Corral", "url": "https://questionsmedicales.fr/author/Javier%20Corral", "affiliation": { "@type": "Organization", "name": "Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain." } }, { "@type": "Person", "name": "Irene Martínez-Martínez", "url": "https://questionsmedicales.fr/author/Irene%20Mart%C3%ADnez-Mart%C3%ADnez", "affiliation": { "@type": "Organization", "name": "Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, U-765, Center for Biomedical Research on Rare Diseases, Murcia, Spain. Electronic address: immlgi@um.es." } }, { "@type": "Person", "name": "Belén de la Morena-Barrio", "url": "https://questionsmedicales.fr/author/Bel%C3%A9n%20de%20la%20Morena-Barrio", "affiliation": { "@type": "Organization", "name": "Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain." } }, { "@type": "Person", "name": "Zsuzsanna Bereczky", "url": "https://questionsmedicales.fr/author/Zsuzsanna%20Bereczky", "affiliation": { "@type": "Organization", "name": "Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Coronary artery calcium testing in young adults.", "datePublished": "2022-11-07", "url": "https://questionsmedicales.fr/article/36598447", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/HCO.0000000000001006" } }, { "@type": "ScholarlyArticle", "name": "Who are relatives? Young adults, relatives and professionals' perceptions of relatives during the rehabilitation of young adults with a severe acquired brain injury.", "datePublished": "2022-05-13", "url": "https://questionsmedicales.fr/article/35559686", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/09638288.2022.2072959" } }, { "@type": "ScholarlyArticle", "name": "Predicting timely transfer to adult care in a cohort of autistic adolescents and young adults.", "datePublished": "2023-09-13", "url": "https://questionsmedicales.fr/article/37703269", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0289982" } }, { "@type": "ScholarlyArticle", "name": "Localised Synovial Sarcoma in Adolescents and Young Adults Versus Adults - Is There a Difference in Outcome?", "datePublished": "2022-12-27", "url": "https://questionsmedicales.fr/article/36577552", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clon.2022.11.020" } }, { "@type": "ScholarlyArticle", "name": "A Comprehensive Analysis of Speech Disfluencies in Autistic Young Adults and Control Young Adults: Group Differences in Typical, Stuttering-Like, and Atypical Disfluencies.", "datePublished": "2023-02-10", "url": "https://questionsmedicales.fr/article/36763844", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2022_JSLHR-22-00265" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Utilisations thérapeutiques", "item": "https://questionsmedicales.fr/mesh/D045506" }, { "@type": "ListItem", "position": 5, "name": "Agents hématologiques", "item": "https://questionsmedicales.fr/mesh/D006401" }, { "@type": "ListItem", "position": 6, "name": "Anticoagulants", "item": "https://questionsmedicales.fr/mesh/D000925" }, { "@type": "ListItem", "position": 7, "name": "Antithrombiniques", "item": "https://questionsmedicales.fr/mesh/D000991" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Antithrombiniques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Antithrombiniques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Antithrombiniques", "description": "Comment diagnostiquer une thrombose ?\nQuels tests pour évaluer l'anticoagulation ?\nQuels symptômes indiquent une embolie ?\nComment détecter une insuffisance veineuse ?\nQuels signes cliniques d'une thrombose veineuse ?", "url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=Young+Adult&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Antithrombiniques", "description": "Quels sont les symptômes d'une thrombose ?\nComment reconnaître une embolie pulmonaire ?\nQuels symptômes d'une hémorragie ?\nQuels signes d'une thrombopénie ?\nComment se manifeste une crise thromboembolique ?", "url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=Young+Adult&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Antithrombiniques", "description": "Comment prévenir les thromboses ?\nQuels conseils pour les patients à risque ?\nComment utiliser les bas de compression ?\nQuels aliments éviter pour prévenir les caillots ?\nComment gérer les facteurs de risque ?", "url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=Young+Adult&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Antithrombiniques", "description": "Quels médicaments sont des antithrombiniques ?\nComment administrer l'héparine ?\nQuels sont les effets secondaires des anticoagulants ?\nComment surveiller l'efficacité des anticoagulants ?\nQuels traitements pour la thrombose veineuse ?", "url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=Young+Adult&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Antithrombiniques", "description": "Quelles sont les complications des anticoagulants ?\nQuels risques d'une surdose d'anticoagulants ?\nComment gérer une hémorragie sous anticoagulants ?\nQuelles sont les complications de la thrombose ?\nQuels effets à long terme des anticoagulants ?", "url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=Young+Adult&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Antithrombiniques", "description": "Quels sont les facteurs de risque de thrombose ?\nComment l'âge influence-t-il le risque ?\nQuel rôle joue le tabagisme ?\nComment les maladies chroniques affectent-elles le risque ?\nQuel impact a la grossesse sur le risque ?", "url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=Young+Adult&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une thrombose ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic de thrombose se fait par échographie, D-dimères et examens cliniques." } }, { "@type": "Question", "name": "Quels tests pour évaluer l'anticoagulation ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent le temps de prothrombine (TP) et l'INR pour surveiller l'anticoagulation." } }, { "@type": "Question", "name": "Quels symptômes indiquent une embolie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur thoracique, essoufflement et toux avec sang." } }, { "@type": "Question", "name": "Comment détecter une insuffisance veineuse ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'insuffisance veineuse se détecte par examen physique et Doppler veineux." } }, { "@type": "Question", "name": "Quels signes cliniques d'une thrombose veineuse ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent œdème, rougeur, chaleur et douleur au niveau de la jambe." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une thrombose ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, gonflement, rougeur et chaleur dans la zone affectée." } }, { "@type": "Question", "name": "Comment reconnaître une embolie pulmonaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent douleur thoracique aiguë, essoufflement et tachycardie." } }, { "@type": "Question", "name": "Quels symptômes d'une hémorragie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent saignements inhabituels, ecchymoses et fatigue excessive." } }, { "@type": "Question", "name": "Quels signes d'une thrombopénie ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des saignements fréquents, des ecchymoses et des pétéchies." } }, { "@type": "Question", "name": "Comment se manifeste une crise thromboembolique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par une douleur soudaine, un essoufflement et une cyanose." } }, { "@type": "Question", "name": "Comment prévenir les thromboses ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut l'exercice régulier, l'hydratation et l'évitement de la sédentarité." } }, { "@type": "Question", "name": "Quels conseils pour les patients à risque ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les patients à risque doivent suivre un traitement anticoagulant et éviter les voyages longs." } }, { "@type": "Question", "name": "Comment utiliser les bas de compression ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les bas de compression aident à améliorer la circulation et à réduire le risque de thrombose." } }, { "@type": "Question", "name": "Quels aliments éviter pour prévenir les caillots ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les aliments riches en vitamine K comme les légumes à feuilles vertes si sous anticoagulants." } }, { "@type": "Question", "name": "Comment gérer les facteurs de risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Gérer les facteurs de risque inclut le contrôle du poids, l'arrêt du tabac et le traitement des maladies chroniques." } }, { "@type": "Question", "name": "Quels médicaments sont des antithrombiniques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antithrombiniques incluent l'héparine, la warfarine et les nouveaux anticoagulants." } }, { "@type": "Question", "name": "Comment administrer l'héparine ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "L'héparine est administrée par injection sous-cutanée ou intraveineuse selon les besoins." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des anticoagulants ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent saignements, ecchymoses et réactions allergiques." } }, { "@type": "Question", "name": "Comment surveiller l'efficacité des anticoagulants ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité se surveille par des tests sanguins réguliers comme l'INR et le temps de prothrombine." } }, { "@type": "Question", "name": "Quels traitements pour la thrombose veineuse ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent anticoagulants, compression et parfois intervention chirurgicale." } }, { "@type": "Question", "name": "Quelles sont les complications des anticoagulants ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent hémorragies, thrombopénie et interactions médicamenteuses." } }, { "@type": "Question", "name": "Quels risques d'une surdose d'anticoagulants ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une surdose peut entraîner des saignements graves et nécessite une attention médicale immédiate." } }, { "@type": "Question", "name": "Comment gérer une hémorragie sous anticoagulants ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "En cas d'hémorragie, il faut arrêter l'anticoagulant et consulter un médecin rapidement." } }, { "@type": "Question", "name": "Quelles sont les complications de la thrombose ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'embolie pulmonaire, le syndrome post-thrombotique et la douleur chronique." } }, { "@type": "Question", "name": "Quels effets à long terme des anticoagulants ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les effets à long terme peuvent inclure des saignements récurrents et des problèmes de coagulation." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de thrombose ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'obésité, l'immobilité, les antécédents familiaux et certaines maladies." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le risque de thrombose augmente avec l'âge en raison de la diminution de la circulation sanguine." } }, { "@type": "Question", "name": "Quel rôle joue le tabagisme ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme augmente le risque de thrombose en favorisant l'inflammation et la coagulation." } }, { "@type": "Question", "name": "Comment les maladies chroniques affectent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les maladies chroniques comme le diabète et l'hypertension augmentent le risque de thrombose." } }, { "@type": "Question", "name": "Quel impact a la grossesse sur le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "La grossesse augmente le risque de thrombose en raison des changements hormonaux et circulatoires." } } ] } ] }

Sources (10000 au total)

Coronary artery calcium testing in young adults.

To provide a summary of recent literature on coronary artery calcium testing (CAC) for risk stratification in young adults <45 years old.... One of every ten young adults in the general population, and one out of every three young adults with traditional atherosclerotic cardiovascular disease (ASCVD) risk factors, have CAC. While the defin... The identification of premature CAC is important because it suggests that calcific plaque can be detected with modern imaging earlier in the natural history than previously thought. Taken together, th...

Who are relatives? Young adults, relatives and professionals' perceptions of relatives during the rehabilitation of young adults with a severe acquired brain injury.

This paper explores the perception of "relatives" during the rehabilitation of young adults with severe acquired brain injury (SABI).... This longitudinal qualitative study followed eight young adults with a SABI from hospital discharge to a year and a half after discharge. The design encompassed professional records, interviews, and s... Social relations engaged as relatives during rehabilitation are to a large extent determined by the perceptions of professionals and the parents of the young adult. These perceptions contain a limited... The authors suggest a professional rethinking of who "relatives" are as well as considering these social ties as dynamic. Implications for rehabilitationRehabilitation professionals must be aware of a...

Predicting timely transfer to adult care in a cohort of autistic adolescents and young adults.

The transition from pediatric to adult care is a challenge for autistic adolescents and young adults. Data on patient features associated with timely transfer between pediatric and adult health care a... We analyzed pediatric and adult electronic medical record data from a cohort of adolescents and young adults who established with a primary-care based program for autistic adolescents and young adults... Total outpatient encounters and total encounters in pediatric care showed good ability to predict timely transfer to adult health care in a population of autistic adolescents and young adults....

Localised Synovial Sarcoma in Adolescents and Young Adults Versus Adults - Is There a Difference in Outcome?

Synovial sarcomas are a rare subgroup of soft-tissue sarcoma arising in adolescents and young adults (AYA) and in adult patients. The objective of our analysis was to investigate the outcomes and pote... In total, 51 patients (25 AYA and 26 adult) were identified and evaluated in this retrospective single centre analysis. Baseline characteristics, treatment and outcome were assessed.... The predominant subtype in both groups was monophasic synovial sarcoma (17 AYA and 21 adult) and the most common site was the extremities (14 and 19 patients) with deep tumour location in both groups ... AYA and adult patients showed no significant difference in terms of overall survival. Male gender, tumour size >5 cm and progressive disease were prognostic markers for worse outcome, whereas tumour l...

A Comprehensive Analysis of Speech Disfluencies in Autistic Young Adults and Control Young Adults: Group Differences in Typical, Stuttering-Like, and Atypical Disfluencies.

The purpose of this study was to examine the nature of speech disfluencies in autistic young adults and controls by using a wide-range disfluency classification of typical disfluencies (TD; i.e., fill... Thirty-two autistic young adults and 35 controls completed a narrative telling task based on socially complex events. Frequencies of total disfluencies, TD, SLD, AD and stuttering severity were compar... The overall frequency of disfluencies was significantly higher in the autistic group and significant between-group differences were found for all disfluency categories. The autistic group produced sig... Disfluent speech can be challenging for effective communication. This study revealed that the speech of autistic young adults was highly more disfluent than that of the controls. The findings provide ...

Ambivalence and Stigma Beliefs About Medication Treatment Among Young Adults With Opioid Use Disorder: A Qualitative Exploration of Young Adults' Perspectives.

Young adults with opioid use disorder (OUD) have low engagement in treatment with medication for opioid use disorder (MOUD). The objective of this study is to explore the beliefs and attitudes about M... We conducted a single-site qualitative study of 20 young adults ages 18-29 years with a diagnosis of OUD receiving care at an outpatient program and who spoke English. We used a flexible interview gui... We identified three themes. First, participants perceived being on MOUD as stigmatizing. They regarded MOUD as lifesaving but ultimately as a "crutch" hindering their full recovery. Second, young adul... In this study of young adults in treatment for OUD, we found that stigma and ambivalence concerning MOUD could explain young adults' low engagement in care. Interventions addressing concerns about the...

Favorable Survival After Screening for Young-Onset Colorectal Cancer: Benefits of Screening in Young Adults.

The increasing incidence and mortality of young-onset colorectal cancer has drawn increasing attention. However, screening for young adults is controversial given the limited evidence regarding its ef... We aimed to clarify the characteristics of young-onset colorectal cancer and to compare long-term outcomes of screening-detected colorectal cancer and non-screening-detected colorectal cancer.... This was a retrospective cohort study.... This study evaluated data from a colorectal cancer registry and medical records at a tertiary Japanese cancer center.... All patients with colorectal cancer who were registered at a Japanese tertiary cancer center between January 2007 and December 2016 were included.... The colorectal cancer cases were categorized as screening-detected colorectal cancer and non-screening-detected colorectal cancer, and patients were categorized into 3 age groups: <50 years (young-ons... A total of 4345 patients were identified, with a median follow-up of 4.6 years. Relative to 50- to 75-year-old individuals, young-onset colorectal cancer was linked to a higher proportion of rectal ca... The findings were limited by the retrospective analysis from a single center.... Young-onset colorectal cancer was more likely to present at an advanced stage and had a lower rate of screening-detected colorectal cancer. Nevertheless, young-onset screening-detected colorectal canc... ANTECEDENTES:La creciente incidencia y mortalidad del cáncer colorrectal en paciente joven ha atraído una atención cada vez mayor. Sin embargo, el cribado para adultos jóvenes es controvertido, dado l...

Speech disfluencies in bilingual Greek-English young adults.

The purpose of this study was to investigate the frequency and types of disfluencies in Greek-English bilingual adults across naturalistic speech samples and compare frequency and types of disfluencie... Participants in the study included 26 Greek-English bilingual young adults. All participants were sequential bilinguals, whose first language was Greek and second language was English. Two speech samp... Results indicated that participants produced more typical disfluencies in English compared to Greek across speaking samples. The most frequent types of disfluencies were filled pauses and vowel prolon... Our results revealed differences in the types and frequencies of disfluencies produced in participants' native compared to their second language. Results add to the growing body of literature addressi...